首页> 外文会议>International work-conference on bioinformatics and biomedical engineering >Controlled Release of Metformin Loaded Polyvinyl Alcohol (PVA) Microbubble/Nanoparticles Using Microfluidic Device for the Treatment of Type 2 Diabetes Mellitus
【24h】

Controlled Release of Metformin Loaded Polyvinyl Alcohol (PVA) Microbubble/Nanoparticles Using Microfluidic Device for the Treatment of Type 2 Diabetes Mellitus

机译:使用微流体装置控制二甲双胍负载的聚乙烯醇(PVA)微泡/纳米颗粒的控释,用于治疗2型糖尿病

获取原文

摘要

Nowadays it became obvious that a relentless increase in Type 2 diabetes mellitus (T2DM), affecting the economically affluent countries, is gradually afflicting also the developing world. The currently used drugs in the treatment of T2DM have inefficient glucose control and carry serious side effects. In this study, nano-sized uniform particles were produced by microfluidic method by the explosion of microbubbles. Morphological (SEM), molecular interactions between the components (FT-iR), drug release test by UV spectroscopy measurement were carried out after production process. When microbubbles and nanoparticles, optical microscope and SEM images obtained were examined, it was observed that metformin was successfully loaded into nanoparticles. The diameter of the microbubbles and nanoparticles was 104 ± 91 μm and 116 ± 13 nm, respectively. Metformin was released in a controlled manner at pH 1.2 for 390 min. It is promising in the treatment of T2DM with the controlled release ability of metformin loaded nonoparticles.
机译:如今,显而易见的是,影响经济上富裕国家的2型糖尿病(T2DM)持续增加,也正在逐渐困扰着发展中世界。当前用于治疗T2DM的药物具有低效的葡萄糖控制并且具有严重的副作用。在这项研究中,通过微泡的爆炸,通过微流体方法产生了纳米尺寸的均匀颗粒。在生产过程之后进行了形态学(SEM),组分之间的分子相互作用(FT-iR),通过紫外光谱测量的药物释放测试。当检查微泡和纳米颗粒时,检查获得的光学显微镜和SEM图像,观察到二甲双胍成功地装载到纳米颗粒中。微泡和纳米颗粒的直径分别为104±91μm和116±13 nm。二甲双胍在pH 1.2下以受控方式释放390分钟。具有负载二甲双胍的非颗粒的控释能力在治疗T2DM中很有前途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号